Cases - Business

Why is there a business cycle? Someone once noted that people could tolerate any condition except the possibility of one. This one condition is prolong period

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

s of prosperity. Incredible as it seems, this observation contains more than just a kernel of truth, and helps to explain where we are in our current business c

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ycle.

When the economy starts to recover from a stiff downturn, people are understandably doubtful about the tenacity of the young expansion. They hold back on

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

their discretionary spending and their use of debt. As the upswing continues to gather force, people tend to become less risk averse. You might say that the g

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

reed factor becomes more prevalent.

As the upturn ages, people become more confident and think that the expansion will last indefinitely. (This has a similar r

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ing to peoples’ attitudes towards real estate today.) Business people take on more debt to leverage their profit margins. The consumer will also be increasin

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

g their debt burdens to finance their growing consumption habit. This increase confidence of consumers is also reflected in their disregard of saving. Soon a

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

oint of no return is reached where the cost of servicing the debt is growing faster than consumers’ income. This scenario also holds true for over-indebted busi

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

nesses.

Now the expansion starts to stall because businesses and consumers can not sustain this level of credit expansion. A period of credit liquidation ensue

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

s and a new downturn begins. The severity of the downturn depends on several factors. These include the oversupply of goods and services, the level of debt bui

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ldup, and government economic policies (namely tax and trade policies).

The business cycle will always be with us. You might say it is the result of the geneti

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

c make-up of mortals. No government policy or regulation can abolish it.

For argument purposes, let’s say it is possible to eliminate the business cycle. Then

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

the question is--what is the price to be paid. What price you ask! Yes, there is always a price because the cardinal law of economics is--there is no such thi

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ng as a free lunch.

The price paid is lost opportunities and slower long-term economic growth. Downturns, recessions as they are called, have a beneficial purp

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

se. Their purpose is to provide renewed liquidity to the business system. Think of it as the catharsis of the economic system. Recessions cleanse the system o

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

f marginal companies and transfer their resources to stronger more productive enterprises. They also force consumers to start saving more to pay-off some of the

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ir massive debts they have accumulated during the expansion. This sets the stage for the next upward expansion. Without recessions there would be stagnation.

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

Recessions can be painful for most, but a time of great opportunity for some. Downturns provide the opportunities for those clever individuals, who have the

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

wherewithal (the liquidity), to purchase assets on the cheap. These assets are then transferred into more productive hands, and the economy benefits.

No matter

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

how many rules or laws politicians put in place, the business cycle is here to stay. Your goal is to take advantage of swings in the cycle to gain market share

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.cases.org.ua/article/3572/cases-Profiting-From-the-Business-Cycle.html">Profiting From the Business Cycle</a>

BB link (for phorums):
[url=http://www.cases.org.ua/article/3572/cases-Profiting-From-the-Business-Cycle.html]Profiting From the Business Cycle[/url]

The food services industry has developed a lot during these past years, mainly because it is essential for restaurants to work proficiently by stocking restaurant equipment and supplies to meet every possible customer demand.

LLCs, or limited liability companies, have become more and more popular, especially in Nevada. The primary reason for popularity of LLCs is their ability to combine the personal liability protection of corporations with attractive tax benefits and the simplicity of forging a partnership. In addition, they are extremely flexible and require less paperwork. LLCs can be set up as new entities, or converted from an existing business. Estimates reveal that Nevada, with 40,000 LLCs in 2005, has more than the corporate-friendly state of Delaware.

Tags

Links

Cases - Profiting From the Business Cycle

Related Articles: